Self-reports by patients revealed a decreasing trend of topical rapamycin use with age; however, the n values were very low (Fig. 3 C).
← all excerpts
Cutaneous manifestations-associated with tuberous sclerosis complex and the use of topical rapamycin in the United States: a sub-analysis of an international survey of caregivers and patients.
1
—
—